2.2. Decreased Expression and Activity of KCa3.1 by Treatment with the Pan-HDACi, Vorinostat, and HDAC2- and HDAC3-Selective HDACis in CD4+ T Cells of IBD Model Mice. Here, KCNN4 is linked to inflammatory bowel disease.